Health Care · S&P 500
Moderna
A U.S. biotech company developing medicines such as its COVID-19 vaccine using messenger RNA technology. S&P 500 constituent. Sector: Health Care (Biotechnology). Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
MRNA Updated Jul 11, 2026 1 AI consumers· 1 recurring
Annual return · 2026-07-10'21+143.1%'22-29.3%'23-44.6%'24-58.2%'25-29.1%YTD+131.5%
Money in ▸·
Moderna~$3.2B
▸ Money out·
Financials & Segments
- Total revenue · ~$3.2B (FY2024)
- Segments · COVID-19 vaccine (Spikevax) · RSV vaccine · Other & collaboration
Revenue from
No refined links yet.
Pays to
No refined links yet.